5-Amino-1MQ Protocol Mistakes & Troubleshooting I can't sleep after starting Insomnia is most often linked in reports to evening or midday dosing rather than morning dosing
However, headache incidence rates were similar between AOD-9604 and placebo groups, suggesting that many cases represented background occurrence rather than treatment-related effects
AOD 9604 is a fragment of human growth hormone studied for its effect on fat metabolism, with a real but modest evidence base and an important regulatory caveat: it is not an FDA-approved weight loss drug
What testing information is available for 5-AMINO-1MQ
The injection sites are: Thigh: This site works best if you're self-administering your own injections, or if you're giving an injection to an infant or child
By downregulating NNMT activity, research shows 5Amino1MQ may support increased NAD availability, enhanced mitochondrial function, and improved metabolic efficiency